Streamline Health Solutions, Inc. (STRM)
USD 2.47
(8.36%)
USD 2.47
(8.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.56 Million USD | 8.38% |
| 2022 | 9.74 Million USD | -3.87% |
| 2021 | 10.14 Million USD | 272.69% |
| 2020 | 2.72 Million USD | -28.86% |
| 2019 | 3.82 Million USD | -3.12% |
| 2018 | 3.94 Million USD | -17.28% |
| 2017 | 4.77 Million USD | -20.06% |
| 2016 | 5.97 Million USD | -37.75% |
| 2015 | 9.59 Million USD | -18.08% |
| 2014 | 11.7 Million USD | 24.71% |
| 2013 | 9.38 Million USD | -31.91% |
| 2012 | 13.78 Million USD | 92.36% |
| 2011 | 7.16 Million USD | 418.0% |
| 2010 | 1.38 Million USD | 5.54% |
| 2009 | 1.31 Million USD | 63.87% |
| 2008 | 800 Thousand USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 1.14 Million USD | -48.61% |
| 2005 | 2.23 Million USD | 2.95% |
| 2004 | 2.16 Million USD | 56.17% |
| 2003 | 1.38 Million USD | -61.38% |
| 2002 | 3.59 Million USD | -28.11% |
| 2001 | 5 Million USD | -16.67% |
| 2000 | 6 Million USD | -17.81% |
| 1999 | 7.3 Million USD | 21.67% |
| 1998 | 6 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 600 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 12.42 Million USD | 17.6% |
| 2024 Q2 | 12.46 Million USD | 0.31% |
| 2023 Q1 | 9.61 Million USD | -1.35% |
| 2023 Q3 | 9.79 Million USD | 2.89% |
| 2023 Q2 | 9.51 Million USD | -1.04% |
| 2023 Q4 | 10.56 Million USD | 7.9% |
| 2023 FY | 10.56 Million USD | 8.38% |
| 2022 FY | 9.74 Million USD | -3.87% |
| 2022 Q3 | 9.92 Million USD | -1.55% |
| 2022 Q2 | 10.08 Million USD | -0.3% |
| 2022 Q1 | 10.11 Million USD | -0.29% |
| 2022 Q4 | 9.74 Million USD | -1.78% |
| 2021 FY | 10.14 Million USD | 272.69% |
| 2021 Q4 | 10.14 Million USD | -0.27% |
| 2021 Q1 | 2.67 Million USD | -1.65% |
| 2021 Q2 | 330 Thousand USD | -87.67% |
| 2021 Q3 | 10.16 Million USD | 2981.21% |
| 2020 FY | 2.72 Million USD | -28.86% |
| 2020 Q4 | 2.72 Million USD | -1.48% |
| 2020 Q3 | 2.76 Million USD | -1.5% |
| 2020 Q2 | 2.8 Million USD | -0.92% |
| 2020 Q1 | 2.83 Million USD | -26.01% |
| 2019 Q1 | 3.81 Million USD | -3.44% |
| 2019 Q4 | 3.82 Million USD | 10.17% |
| 2019 Q2 | 4.67 Million USD | 22.72% |
| 2019 FY | 3.82 Million USD | -3.12% |
| 2019 Q3 | 3.47 Million USD | -25.78% |
| 2018 Q3 | 4.1 Million USD | -3.11% |
| 2018 Q1 | 4.62 Million USD | -3.16% |
| 2018 FY | 3.94 Million USD | -17.28% |
| 2018 Q2 | 4.23 Million USD | -8.36% |
| 2018 Q4 | 3.94 Million USD | -3.8% |
| 2017 Q1 | 5.77 Million USD | -3.23% |
| 2017 Q3 | 4.92 Million USD | -3.39% |
| 2017 Q2 | 5.09 Million USD | -11.79% |
| 2017 Q4 | 4.77 Million USD | -3.06% |
| 2017 FY | 4.77 Million USD | -20.06% |
| 2016 Q3 | 6.55 Million USD | -4.17% |
| 2016 Q1 | 8.95 Million USD | -6.63% |
| 2016 Q2 | 6.83 Million USD | -23.65% |
| 2016 Q4 | 5.97 Million USD | -8.87% |
| 2016 FY | 5.97 Million USD | -37.75% |
| 2015 Q4 | 9.59 Million USD | -3.24% |
| 2015 Q1 | 11.39 Million USD | -2.68% |
| 2015 Q2 | 10.33 Million USD | -9.32% |
| 2015 Q3 | 9.91 Million USD | -4.06% |
| 2015 FY | 9.59 Million USD | -18.08% |
| 2014 Q2 | 9.83 Million USD | 8.57% |
| 2014 Q1 | 9.06 Million USD | -3.48% |
| 2014 FY | 11.7 Million USD | 24.71% |
| 2014 Q3 | 9.49 Million USD | -3.52% |
| 2014 Q4 | 11.7 Million USD | 23.35% |
| 2013 FY | 9.38 Million USD | -31.91% |
| 2013 Q4 | 9.38 Million USD | -26.84% |
| 2013 Q1 | 13.4 Million USD | -2.76% |
| 2013 Q3 | 12.83 Million USD | -2.37% |
| 2013 Q2 | 13.14 Million USD | -1.98% |
| 2012 FY | 13.78 Million USD | 92.36% |
| 2012 Q2 | 4.12 Million USD | -42.5% |
| 2012 Q1 | 7.16 Million USD | -0.04% |
| 2012 Q4 | 13.78 Million USD | -22.88% |
| 2012 Q3 | 17.87 Million USD | 333.92% |
| 2011 FY | 7.16 Million USD | 418.0% |
| 2011 Q4 | 7.16 Million USD | 292.04% |
| 2011 Q2 | 1.43 Million USD | -14.99% |
| 2011 Q1 | 1.69 Million USD | 22.15% |
| 2011 Q3 | 1.82 Million USD | 27.24% |
| 2010 Q3 | 2.63 Million USD | 13.13% |
| 2010 Q1 | 1.88 Million USD | 44.09% |
| 2010 FY | 1.38 Million USD | 5.54% |
| 2010 Q2 | 2.32 Million USD | 23.23% |
| 2010 Q4 | 1.38 Million USD | -47.46% |
| 2009 Q2 | 800 Thousand USD | 0.0% |
| 2009 Q1 | 800 Thousand USD | 0.0% |
| 2009 FY | 1.31 Million USD | 63.87% |
| 2009 Q3 | 1.9 Million USD | 137.5% |
| 2009 Q4 | 1.31 Million USD | -31.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | 800 Thousand USD | -60.0% |
| 2008 FY | 800 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | 2 Million USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q1 | 124.88 Thousand USD | -89.11% |
| 2006 Q4 | 1.14 Million USD | -1.86% |
| 2006 Q3 | 1.16 Million USD | -1.8% |
| 2006 Q2 | 1.19 Million USD | -46.17% |
| 2006 Q1 | 2.21 Million USD | -0.93% |
| 2006 FY | 1.14 Million USD | -48.61% |
| 2005 Q2 | 2.28 Million USD | -3.1% |
| 2005 Q1 | 2.36 Million USD | 8.97% |
| 2005 Q3 | 2.09 Million USD | -8.28% |
| 2005 FY | 2.23 Million USD | 2.95% |
| 2005 Q4 | 2.23 Million USD | 6.29% |
| 2004 FY | 2.16 Million USD | 56.17% |
| 2004 Q4 | 2.16 Million USD | -28.32% |
| 2004 Q3 | 3.02 Million USD | -19.99% |
| 2004 Q2 | 3.78 Million USD | 352.9% |
| 2004 Q1 | 834.63 Thousand USD | -39.88% |
| 2003 FY | 1.38 Million USD | -61.38% |
| 2003 Q4 | 1.38 Million USD | -28.48% |
| 2003 Q3 | 1.94 Million USD | -22.14% |
| 2003 Q2 | 2.49 Million USD | -18.1% |
| 2003 Q1 | 3.04 Million USD | -15.31% |
| 2002 Q1 | 4.5 Million USD | -10.0% |
| 2002 Q3 | 4.13 Million USD | -11.21% |
| 2002 FY | 3.59 Million USD | -28.11% |
| 2002 Q2 | 4.65 Million USD | 3.43% |
| 2002 Q4 | 3.59 Million USD | -13.02% |
| 2001 Q2 | 6 Million USD | 0.0% |
| 2001 FY | 5 Million USD | -16.67% |
| 2001 Q1 | 6 Million USD | 0.0% |
| 2001 Q3 | 5.5 Million USD | -8.33% |
| 2001 Q4 | 5 Million USD | -9.09% |
| 2000 FY | 6 Million USD | -17.81% |
| 2000 Q2 | 6 Million USD | 0.0% |
| 2000 Q4 | 6 Million USD | 0.0% |
| 2000 Q3 | 6 Million USD | 0.0% |
| 2000 Q1 | 6 Million USD | -17.81% |
| 1999 Q4 | 7.3 Million USD | 21.67% |
| 1999 FY | 7.3 Million USD | 21.67% |
| 1999 Q3 | 6 Million USD | 0.0% |
| 1999 Q1 | 6 Million USD | 0.0% |
| 1999 Q2 | 6 Million USD | 0.0% |
| 1998 FY | 6 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 6 Million USD | 0.0% |
| 1998 Q3 | 6 Million USD | 0.0% |
| 1998 Q2 | 6 Million USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | -100.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 FY | 600 Thousand USD | 0.0% |
| 1995 Q4 | 600 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Augmedix, Inc. | 25.84 Million USD | 59.119% |
| OneMedNet Corporation | 5.1 Million USD | -107.123% |
| Minerva Surgical, Inc. | 39.69 Million USD | 73.379% |
| CareCloud, Inc. | 14.73 Million USD | 28.283% |
| CareCloud, Inc. | 14.73 Million USD | 28.283% |
| HealthEquity, Inc. | 933.14 Million USD | 98.868% |
| iCoreConnect Inc. | 7.87 Million USD | -34.097% |
| Progyny, Inc. | 19.39 Million USD | 45.508% |
| Renalytix Plc | 8.53 Million USD | -23.796% |
| Schrödinger, Inc. | 127.88 Million USD | 91.738% |
| Simulations Plus, Inc. | 475 Thousand USD | -2124.421% |
| SOPHiA GENETICS SA | 18.6 Million USD | 43.197% |
| Omnicell, Inc. | 614.09 Million USD | 98.279% |
| BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 99.712% |
| Inovalon Holdings, Inc. | 897.3 Million USD | 98.822% |
| Ontrak, Inc. | 1.68 Million USD | -525.577% |
| Nutex Health, Inc. | 275.75 Million USD | 96.168% |
| GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.893% |
| Sharecare, Inc. | 2.34 Million USD | -350.576% |
| Aclarion, Inc. | 1.12 Million USD | -838.596% |
| CareMax, Inc. | 491.93 Million USD | 97.852% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Forian Inc. | 23 Million USD | 54.064% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 119.77 Million USD | 91.178% |
| SCWorx Corp. | 90.35 Thousand USD | -11593.357% |
| Definitive Healthcare Corp. | 267.92 Million USD | 96.056% |
| 10x Genomics, Inc. | 95.37 Million USD | 88.921% |
| Zhongchao Inc. | 808.15 Thousand USD | -1207.421% |
| Accolade, Inc. | 241.64 Million USD | 95.628% |
| MSP Recovery, Inc. | 679.32 Million USD | 98.445% |
| R1 RCM Inc. | 1.74 Billion USD | 99.393% |
| Spok Holdings, Inc. | 11.08 Million USD | 4.691% |
| Privia Health Group, Inc. | 8.28 Million USD | -27.47% |
| EUDA Health Holdings Limited | 3.37 Million USD | -213.111% |
| TruBridge, Inc. | 203.28 Million USD | 94.802% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 99.712% |
| Sharecare, Inc. | 2.34 Million USD | -350.576% |
| Health Catalyst, Inc. | 249.06 Million USD | 95.758% |
| GoodRx Holdings, Inc. | 711.07 Million USD | 98.514% |
| Premier, Inc. | 126 Million USD | 91.614% |
| HealthStream, Inc. | 23.22 Million USD | 54.498% |
| Certara, Inc. | 298.19 Million USD | 96.457% |
| GeneDx Holdings Corp. | 119.77 Million USD | 91.178% |
| Ontrak, Inc. | 1.68 Million USD | -525.577% |
| SHL Telemedicine Ltd. | 19.85 Million USD | 46.774% |
| CareCloud, Inc. | 14.73 Million USD | 28.283% |
| EUDA Health Holdings Limited | 3.37 Million USD | -213.111% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 128.67 Thousand USD | -8111.194% |
| CareMax, Inc. | 491.93 Million USD | 97.852% |
| Healthcare Triangle, Inc. | 4.31 Million USD | -144.753% |
| National Research Corporation | 38.95 Million USD | 72.877% |
| Aclarion, Inc. | 1.12 Million USD | -838.596% |
| OptimizeRx Corporation | 36.82 Million USD | 71.307% |